A groundbreaking modelling study has revealed that South Africa faces an staggering burden of depression, with an estimated 3.84 million new episodes occurring in 2024 alone. This figure translates to well over three million individuals developing the condition each year, highlighting a persistent public health challenge that demands urgent attention.

Conducted by researchers from the University of Cape Town's Centre for Infectious Disease Epidemiology and Research (CIDER), the study employs a sophisticated Bayesian spatiotemporal model calibrated against data from nine national household surveys spanning 2002 to 2024, alongside smaller targeted studies. Led by Dr. Leigh Johnson and Professor Lara Fairall, this work provides the most comprehensive estimates to date on depression prevalence, incidence, and antidepressant utilization in the country.

Key Findings from the Modelling Study

The research indicates that depression point prevalence among South Africans aged 15 and older stood at 4.5% in mid-2024, affecting more than two million people. This marks a modest decline from 5.1% in 2002, suggesting some progress amid broader health improvements. However, the annual incidence remains alarmingly high, with 3.84 million new episodes reported for 2024—equivalent to roughly 6% of the adult population experiencing a new onset each year.

Lifetime risk is even more striking: approximately 70% of adults will experience at least one episode of depression over their lives, though most endure only a single occurrence without recurrence. This challenges the common perception of depression as a chronically relapsing condition, applicable primarily to a minority of cases.

• Prevalence higher among women (5.3%) than men (3.6%).
• Peaks in those aged 60 and older.
• Association with HIV has weakened, from a 2.2 percentage point gap in 2010 to 1.4 in 2024, likely due to expanded antiretroviral therapy access.

Methodology: Bayesian Spatiotemporal Modelling

The study's Bayesian model integrates temporal trends, spatial variations, and demographic factors to generate robust estimates. Data sources include major surveys like the South African Stress and Health Study, National Income Dynamics Study (NIDS), and recent COVID-19 health behavior assessments. By accounting for diagnostic criteria changes and survey methodologies, the model offers unprecedented granularity, including provincial disparities and projections of antidepressant dispensing patterns.

This approach surpasses traditional cross-sectional analyses by capturing incidence dynamics and lifetime trajectories, revealing that while point prevalence is moderate, the cumulative burden is immense. The preprint, available on medRxiv, underscores the need for such advanced epidemiological tools in resource-constrained settings.

Trends in Depression Over Two Decades

From 2002 to 2024, overall prevalence dipped slightly, driven by reductions in younger cohorts and among people living with HIV. Spatial analysis shows hotspots in rural provinces like Eastern Cape and Limpopo, contrasting urban Gauteng's lower rates, though absolute numbers remain highest in populous areas. The model predicts stabilization unless socioeconomic drivers intensify.

These shifts coincide with HIV treatment scale-up, illustrating how managing comorbidities can alleviate mental health pressures. Yet, post-COVID surveys indicate transient spikes, emphasizing vulnerability to external shocks.

Demographic Disparities: Gender, Age, and HIV Links

Gender imbalance persists: women face 47% higher prevalence, linked to biological factors like hormonal fluctuations, caregiving burdens, and gender-based violence exposure. Age gradients show lowest rates (under 3%) in 15-29 year-olds, rising to over 6% past 60, correlating with retirement stress, isolation, and multimorbidity.

Historically tied to HIV, depression risk has converged as viral suppression improves immune function and reduces stigma. Still, PLHIV exhibit 1.4% higher prevalence, urging integrated care models.

Antidepressant Use: A Stark Treatment Divide

Despite evidence-based efficacy, only 2.8% of adults used antidepressants in 2024—up from 1% in 2008—but woefully inadequate. Usage surges over fourfold in women and twelvefold in privately insured (11%) versus public sector (0.9%) patients. Private rates mirror high-income nations (4-16%), while public lags due to psychiatrist shortages (1 per 100,000), doctor overburden, and nurses barred from prescribing selective serotonin reuptake inhibitors (SSRIs).

This gap exacerbates disability-adjusted life years lost, with depression ranking as South Africa's top cause. Professor Fairall notes, "The study highlights the burden of depression... and stark inequities despite on-paper availability of treatments."

Socioeconomic and Environmental Risk Factors

Poverty, unemployment (over 30%), food insecurity, and inequality fuel depression. Low socioeconomic status correlates with 2-3 times higher odds, mediated by chronic stress and limited coping resources. Gender-based violence affects 1 in 3 women, trauma from apartheid legacies persists, and climate events like floods amplify risks in vulnerable communities.

Urban-rural divides show higher rural incidence due to service deserts, while youth face academic pressures and social media influences. Childhood adversity doubles adult risk, underscoring prevention's role.

University Research Driving Insights

South African universities spearhead mental health epidemiology. UCT's CIDER and Knowledge Translation Unit exemplify this, with Dr. Johnson's Thembisa model now extending to mental disorders. Stellenbosch, Wits, and UKZN contribute cohort studies on student depression (up to 30% prevalence) and interventions.

Such research informs policy, like task-sharing where primary care nurses deliver psychotherapy, proven effective in PRIMSA trials. Academic output positions SA as Africa's leader in mental health RCTs.

Barriers to Treatment and the Massive Gap

Over 90% unmet need stems from human resource shortages (psychiatrists: 17 per million), stigma, transport costs, and cultural beliefs favoring traditional healers. Public facilities prioritize severe cases, leaving mild-moderate untreated. The 2023 National Mental Health Policy Framework calls for regulatory reform, yet implementation lags.

WHO reports align, noting Africa's 1.7% health budget for mental health versus global 2%.

Economic and Societal Impacts

Depression costs SA billions in lost productivity, with absenteeism and presenteeism reducing GDP by 1-2%. Suicide (third-highest in Africa) claims 8,000 lives yearly, disproportionately youth. Family strain and intergenerational transmission perpetuate cycles of poverty.

Promising Solutions and Interventions

• Task-sharing: Train nurses in antidepressants and group interpersonal psychotherapy (proven 50% response rates).
• Digital tools: Apps like StrongMinds reach remote areas.
• Policy: Empower nurses to prescribe SSRIs, integrate mental health into PHC.
• Prevention: School programs targeting trauma, unemployment schemes with psychosocial support.

Dr. Johnson emphasizes, "Major barriers to accessing mental healthcare" in uninsured populations, urging action.

Photo by Claudio Schwarz on Unsplash

Future Outlook and Calls to Action

With aging population and inequality, unchecked depression risks escalation. Yet, modelling enables targeted investments. Universities like UCT advocate scaling evidence-based care, potentially halving incidence via equitable access. Policymakers must operationalize the 2023 framework to bridge the gap, fostering a mentally healthier nation.

For those affected, resources like SADAG helpline offer immediate support.